OpenURL Connection Search

Select item for more details and to access through your institution.

Rituximab-responsive CIDP.
Published in:
2004
By:
- Briani, C.;
- Zara, G.;
- Zambello, R.;
- Trentin, L.;
- Rana, M.;
- Zaja, F.
Publication type:
Letter
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
Published in:
1998
By:
- Damiani, D;
- Michieli, M;
- Ermacora, A;
- Russo, D;
- Fanin, R;
- Zaja, F;
- Baraldo, M;
- Pea, F;
- Furlanut, M;
- Baccarani, M
Publication type:
journal article
The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma.
Published in:
1997
By:
- Silvestri, F;
- Barillari, G;
- Fanin, R;
- Pipan, C;
- Falasca, E;
- Salmaso, F;
- Zaja, F;
- Infanti, L;
- Patriarca, F;
- Botta, G A;
- Baccarani, M
Publication type:
journal article
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Published in:
Rheumatology, 2006, v. 45, n. 7, p. 842
By:
- G. Soardo;
- F. Zaja;
- C. A. Scott;
- G. Ferraccioli
Publication type:
Article
Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.
Published in:
2017
By:
- Puccini, B;
- Nassi, L.;
- Minoia, C.;
- Volpetti, S.;
- Ciancia, R.;
- Riccomagno, P.;
- Di Rocco, A.;
- Mulè, A.;
- Toldo, C.;
- Sassone, M.;
- Guariglia, R.;
- Filì, C.;
- Finolezzi, E.;
- Falorio, S.;
- Zanon, S.;
- Furlan, A.;
- Doa, G.;
- Zaja, F.;
- Riccomagno, P C;
- Mulè, A
Publication type:
journal article
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)
Published in:
2012
By:
- Rigacci L;
- Puccini B;
- Cortelazzo S;
- Gaidano G;
- Piccin A;
- D'Arco A;
- Freilone R;
- Storti S;
- Orciuolo E;
- Zinzani PL;
- Zaja F;
- Bongarzoni V;
- Balzarotti M;
- Rota-Scalabrini D;
- Patti C;
- Gobbi M;
- Carpaneto A;
- Liberati AM;
- Bosi A;
- Iannitto E
Publication type:
Journal Article
Myasthenia gravis after allogeneic bone marrow transplantation.
Published in:
Acta Neurologica Scandinavica, 1997, v. 96, n. 4, p. 256, doi. 10.1111/j.1600-0404.1997.tb00279.x
By:
- Zaja, F.;
- Barillari, G.;
- Russo, D.;
- Silvestri, F.;
- Fanin, R.;
- Baccarani, M.
Publication type:
Article
Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia.
Published in:
La Radiologia Medica, 2010, v. 115, n. 2, p. 205, doi. 10.1007/s11547-009-0433-3
By:
- Cereser, L.;
- Zuiani, C.;
- Graziani, G.;
- Girometti, R.;
- Como, G.;
- Zaja, F.;
- Bazzocchi, M.
Publication type:
Article
Treatment of refractory chronic GVHD with rituximab: a GITMO study.
Published in:
Bone Marrow Transplantation, 2007, v. 40, n. 3, p. 273, doi. 10.1038/sj.bmt.1705725
By:
- Zaja, F.;
- Bacigalupo, A.;
- Patriarca, F.;
- Stanzani, M.;
- Van Lint, M. T.;
- Filì, C.;
- Scimè, R.;
- Milone, G.;
- Falda, M.;
- Vener, C.;
- Laszlo, D.;
- Alessandrino, P. E.;
- Narni, F.;
- Sica, S.;
- Olivieri, A.;
- Sperotto, A.;
- Bosi, A.;
- Bonifazi, F.;
- Fanin, R.
Publication type:
Article
Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion.
Published in:
Bone Marrow Transplantation, 2005, v. 35, n. 5, p. 523, doi. 10.1038/sj.bmt.1704802
By:
- Skert, C.;
- Patriarca, F.;
- Zaja, F.;
- Tomadini, V.;
- Fanin, R.
Publication type:
Article
Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation.
Published in:
Bone Marrow Transplantation, 2004, v. 33, n. 7, p. 751, doi. 10.1038/sj.bmt.1704426
By:
- Fanin, R;
- Patriarca, F.;
- Skert, C.;
- Sperotto, A.;
- Damiani, D.;
- Cerno, M.;
- Geromin, A.;
- Zaja, F.;
- Stocchi, R.;
- Prosdocimo, S.;
- Fili, C.
Publication type:
Article
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia.
Published in:
European Journal of Haematology, 1993, v. 51, n. 2, p. 93, doi. 10.1111/j.1600-0609.1993.tb01599.x
By:
- Zinzani, P. L.;
- Lauria, F.;
- Rondelli, D.;
- Benfenati, D.;
- Raspadori, D.;
- Bocchia, M.;
- Gozzetti, A.;
- Cavo, M.;
- Cirio, T. M.;
- Zaja, F.;
- Russo, D.;
- Fanin, R.;
- Galieni, P.;
- Algeri, R.;
- Fiacchini, M.;
- Tura, S.
Publication type:
Article
Meningeal and cerebral involvement in multiple myeloma patients.
Published in:
Annals of Hematology, 2001, v. 80, n. 12, p. 758, doi. 10.1007/s00277-001-0387-6
By:
- Patriarca, F.;
- Zaja, F.;
- Silvestri, F.;
- Sperotto, A.;
- Scalise, A.;
- Gigli, G.;
- Fanin, R.
Publication type:
Article
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.
Published in:
Leukemia (08876924), 2014, v. 28, n. 3, p. 642, doi. 10.1038/leu.2013.334
By:
- Cortelezzi, A;
- Sciumè, M;
- Liberati, A M;
- Vincenti, D;
- Cuneo, A;
- Reda, G;
- Laurenti, L;
- Zaja, F;
- Marasca, R;
- Chiarenza, A;
- Gritti, G;
- Orsucci, L;
- Storti, S;
- Angelucci, E;
- Cascavilla, N;
- Gobbi, M;
- Mauro, F R;
- Morabito, F;
- Fabris, S;
- Piciocchi, A
Publication type:
Article
RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.80_2879
By:
- Luminari, S.;
- Galimberti, S.;
- Versari, A.;
- Tucci, A.;
- Boccomini, C.;
- Farina, L.;
- Zaja, F.;
- Marcheselli, L.;
- Ferrero, S.;
- Arcaini, L.;
- Pulsoni, A.;
- Musuraca, G.;
- Califano, C.;
- Merli, M.;
- Bari, A.;
- Conconi, A.;
- Giudice, I. del;
- Re, F.;
- Stefani, P. M.;
- Usai, S. V.
Publication type:
Article
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 110, doi. 10.1002/hon.72_2629
By:
- Tiacci, E.;
- De Carolis, L.;
- Simonetti, E.;
- Zaja, F.;
- Capponi, M.;
- Ambrosetti, A.;
- Lucia, E.;
- Antolino, A.;
- Pulsoni, A.;
- Ferrari, S.;
- Zinzani, P.;
- Rigacci, L.;
- Gaidano, G.;
- Della Seta, R.;
- Frattarelli, N.;
- Falcucci, P.;
- Visani, G.;
- Foà, R.;
- Falini, B.
Publication type:
Article
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT).
Published in:
Hematological Oncology, 2019, v. 37, p. 256, doi. 10.1002/hon.65_2630
By:
- Ferreri, A.J.;
- Sassone, M.C.;
- Angelillo, P.;
- Zaja, F.;
- Re, A.;
- Spina, M.;
- Di Rocco, A.;
- Fabbri, A.;
- Stelitano, C.;
- Frezzato, M.;
- Rusconi, C.;
- Zambello, R.;
- Arcari, A.;
- Bertoldero, G.;
- De Lorenzo, D.;
- Volpetti, S.;
- Calimeri, T.;
- Perrone, S.;
- Cecchetti, C.;
- Ciceri, F.
Publication type:
Article
EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 229, doi. 10.1002/hon.43_2630
By:
- Rule, S.;
- Barreto, W.G.;
- Briones, J.;
- Carella, A.M.;
- Casasnovas, O.;
- Pocock, C.;
- Wendtner, C.M.;
- Zaja, F.;
- Robson, S.;
- Tschopp, R.R.;
- Dreyling, M.
Publication type:
Article
THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL.
Published in:
Hematological Oncology, 2019, v. 37, p. 110, doi. 10.1002/hon.72_2629
By:
- Tiacci, E.;
- De Carolis, L.;
- Simonetti, E.;
- Zaja, F.;
- Capponi, M.;
- Ambrosetti, A.;
- Lucia, E.;
- Antolino, A.;
- Pulsoni, A.;
- Ferrari, S.;
- Zinzani, P.;
- Rigacci, L.;
- Gaidano, G.;
- Della Seta, R.;
- Frattarelli, N.;
- Falcucci, P.;
- Visani, G.;
- Foà, R.;
- Falini, B.
Publication type:
Article
LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT).
Published in:
Hematological Oncology, 2019, v. 37, p. 256, doi. 10.1002/hon.65_2630
By:
- Ferreri, A.J.;
- Sassone, M.C.;
- Angelillo, P.;
- Zaja, F.;
- Re, A.;
- Spina, M.;
- Di Rocco, A.;
- Fabbri, A.;
- Stelitano, C.;
- Frezzato, M.;
- Rusconi, C.;
- Zambello, R.;
- Arcari, A.;
- Bertoldero, G.;
- De Lorenzo, D.;
- Volpetti, S.;
- Calimeri, T.;
- Perrone, S.;
- Cecchetti, C.;
- Ciceri, F.
Publication type:
Article
EFFICACY AND SAFETY OF PROLONGED MAINTENANCE WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY INDOLENT NHL: RESULTS OF THE PHASE III MABCUTE STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 229, doi. 10.1002/hon.43_2630
By:
- Rule, S.;
- Barreto, W.G.;
- Briones, J.;
- Carella, A.M.;
- Casasnovas, O.;
- Pocock, C.;
- Wendtner, C.M.;
- Zaja, F.;
- Robson, S.;
- Tschopp, R.R.;
- Dreyling, M.
Publication type:
Article
INTERFERON-FREE ANTIVIRAL TREATMENT IN B-CELL LYMPHOPROLIFERATIVE DISORDERS ASSOCIATED WITH CHRONIC HEPATITIS-C VIRUS INFECTION.
Published in:
Hematological Oncology, 2017, v. 35, p. 145, doi. 10.1002/hon.2437_135
By:
- Frigeni, M.;
- Visco, C.;
- Besson, C.;
- Rattotti, S.;
- Fontaine, H.;
- Goldaniga, M.;
- Visentini, M.;
- Torres, H.A.;
- Peveling ‐ Oberhag, J.;
- Rossotti, R.;
- Zaja, F.;
- Rigacci, L.;
- Merli, M.;
- Dorival, C.;
- Alric, L.;
- Piazza, F.;
- Gentile, M.;
- Ferrari, A.;
- Pirisi, M.;
- Tedeschi, A.
Publication type:
Article
CELL OF ORIGIN COMBINED WITH CNS INTERNATIONAL PROGNOSTIC INDEX IMPROVES IDENTIFICATION OF DLBCL PATIENTS WITH HIGH CNS RELAPSE RISK AFTER INITIAL IMMUNOCHEMOTHERAPY.
Published in:
Hematological Oncology, 2017, v. 35, p. 43, doi. 10.1002/hon.2437_25
By:
- Klanova, M.;
- Sehn, L.H.;
- Bence ‐ Bruckler, I.;
- Cavallo, F.;
- Jin, J.;
- Martelli, M.;
- Stewart, D.;
- Vitolo, U.;
- Zaja, F.;
- Zhang, Q.;
- Mattiello, F.;
- Oestergaard, M.Z.;
- Fingerle ‐ Rowson, G.R.;
- Nielsen, T.;
- Trneny, M.
Publication type:
Article
INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE.
Published in:
Hematological Oncology, 2017, v. 35, p. 109, doi. 10.1002/hon.2437_98
By:
- Tissino, E.;
- Benedetti, D.;
- Herman, S.E.;
- Hacken, E.;
- Ahn, I.E.;
- Chaffee, K.G.;
- Bayer, E.;
- Haerzschel, A.;
- Gutjahr, J.C.;
- Postorino, M.;
- Santinelli, E.;
- Ayed, A.;
- Zaja, F.;
- Chiarenza, A.;
- Chigaev, A.;
- Sklar, L.A.;
- Burger, J.A.;
- Ferrajoli, A.;
- Shanafelt, T.D.;
- Wiestner, A.
Publication type:
Article
NOTCH1 MUTATED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS ARE CHARACTERIZED BY a MYC-RELATED OVEREXPRESSION OF NUCLEOPHOSMIN-1 AND RIBOSOME ASSOCIATED COMPONENTS.
Published in:
Hematological Oncology, 2017, v. 35, p. 57, doi. 10.1002/hon.2437_43
By:
- Pozzo, F.;
- Bittolo, T.;
- Vendramini, E.;
- Bomben, R.;
- Bulian, P.;
- Rossi, F.M.;
- Zucchetto, A.;
- Tissino, E.;
- Degan, M.;
- D'Arena, G.;
- Di Raimondo, F.;
- Zaja, F.;
- Pozzato, G.;
- Rossi, D.;
- Gaidano, G.;
- Del Poeta, G.;
- Gattei, V.;
- Dal Bo, M.
Publication type:
Article
PROGNOSTIC IMPACT OF BCL2 AND MYC EXPRESSION AND TRANSLOCATION IN UNTREATED DLBCL: RESULTS FROM THE PHASE III GOYA STUDY.
Published in:
Hematological Oncology, 2017, v. 35, p. 131, doi. 10.1002/hon.2437_121
By:
- Sehn, L.H.;
- Oestergaard, M.Z.;
- Trněný, M.;
- Bosi, A.;
- Egyed, M.;
- Illes, A.;
- Nakamae, H.;
- Opat, S.;
- Topp, M.;
- Zaja, F.;
- Fingerle ‐ Rowson, G.;
- Lei, G.;
- Nielsen, T.;
- Punnoose, E.A.;
- Rahman, M.;
- Ray, J.;
- Zhang, L.;
- Martelli, M.;
- Vitolo, U.
Publication type:
Article
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL).
Published in:
Hematological Oncology, 2017, v. 35, p. 38, doi. 10.1002/hon.2437_19
By:
- Rigacci, L.;
- Puccini, B.;
- Zinzani, P.;
- Kovalchuk, S.;
- Broccoli, A.;
- Evangelista, A.;
- Gioia, D.;
- Mannelli, L.;
- Castagnoli, A.;
- Santoro, A.;
- Bonfichi, M.;
- Rossi, G.;
- Anastasia, A.;
- Zaja, F.;
- Vitolo, U.;
- Pavone, V.;
- Pulsoni, A.;
- Gaidano, G.;
- Stelitano, C.;
- Salvi, F.
Publication type:
Article
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: An effective but myelosuppressive regimen to be offered to patients with advanced disease.
Published in:
2012
By:
- Tedeschi A;
- Benevolo G;
- Varettoni M;
- Battista ML;
- Zinzani PL;
- Visco C;
- Meneghini V;
- Pioltelli P;
- Sacchi S;
- Ricci F;
- Nichelatti M;
- Zaja F;
- Lazzarino M;
- Vitolo U;
- Morra E
Publication type:
Journal Article
RITUXIMAB IN A CASE OF COLD AGGLUTININ DISEASE.
Published in:
British Journal of Haematology, 2001, v. 115, n. 1, p. 232, doi. 10.1046/j.1365-2141.2001.115_1cr-4.x
By:
- Zaja, F.;
- Russo, D.;
- Fuga, G.;
- Michelutti, T.;
- Sperotto, A.;
- Fanin, R.;
- Baccarani, M.
Publication type:
Article
Temozolomide as salvage treatment in primary brain lymphomas.
Published in:
2007
By:
- Reni, M.;
- Zaja, F.;
- Mason, W.;
- Perry, J.;
- Mazza, E.;
- Spina, M.;
- Bordonaro, R.;
- Ilariucci, F.;
- Faedi, M.;
- Corazzelli, G.;
- Manno, P.;
- Franceschi, E.;
- Pace, A.;
- Candela, M.;
- Abbadessa, A.;
- Stelitano, C.;
- Latte, G.;
- Ferreri, A. J. M.
Publication type:
journal article

Found: 30